Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1260688.RA6KrU_ZwV3xqj4V-0bgwcwUdrtVs2TA_lV2wQotmOtFs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1260688.RA6KrU_ZwV3xqj4V-0bgwcwUdrtVs2TA_lV2wQotmOtFs130_assertion type Assertion NP1260688.RA6KrU_ZwV3xqj4V-0bgwcwUdrtVs2TA_lV2wQotmOtFs130_head.
- NP1260688.RA6KrU_ZwV3xqj4V-0bgwcwUdrtVs2TA_lV2wQotmOtFs130_assertion description "[Additionally, as revealed by the dataset, the upregulation of CENPF mRNA expression in the PCa tissues significantly correlated with a higher Gleason score (GS, P = 0.005), an advanced pathological stage (P = 0.008), the presence of metastasis (P < 0.001), a shorter overall survival (P=0.003) and prostate-specific antigen (PSA) failure (P < 0.001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1260688.RA6KrU_ZwV3xqj4V-0bgwcwUdrtVs2TA_lV2wQotmOtFs130_provenance.
- NP1260688.RA6KrU_ZwV3xqj4V-0bgwcwUdrtVs2TA_lV2wQotmOtFs130_assertion evidence source_evidence_literature NP1260688.RA6KrU_ZwV3xqj4V-0bgwcwUdrtVs2TA_lV2wQotmOtFs130_provenance.
- NP1260688.RA6KrU_ZwV3xqj4V-0bgwcwUdrtVs2TA_lV2wQotmOtFs130_assertion SIO_000772 25647485 NP1260688.RA6KrU_ZwV3xqj4V-0bgwcwUdrtVs2TA_lV2wQotmOtFs130_provenance.
- NP1260688.RA6KrU_ZwV3xqj4V-0bgwcwUdrtVs2TA_lV2wQotmOtFs130_assertion wasDerivedFrom befree-2016 NP1260688.RA6KrU_ZwV3xqj4V-0bgwcwUdrtVs2TA_lV2wQotmOtFs130_provenance.
- NP1260688.RA6KrU_ZwV3xqj4V-0bgwcwUdrtVs2TA_lV2wQotmOtFs130_assertion wasGeneratedBy ECO_0000203 NP1260688.RA6KrU_ZwV3xqj4V-0bgwcwUdrtVs2TA_lV2wQotmOtFs130_provenance.